KB195 / Kaleido Biosci 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
  • ||||||||||  KB195 / Kaleido Biosci
    Enrollment change, Trial completion date, Trial termination, Trial primary completion date:  UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder (clinicaltrials.gov) -  Jan 25, 2022   
    P2,  N=13, Terminated, 
    N=24 --> 13 | Trial completion date: Nov 2021 --> Mar 2021 | Recruiting --> Terminated | Trial primary completion date: Oct 2021 --> Feb 2021; Kaleido Biosciences, Inc. closed the K020-218 trial due to business reasons, and not due to any safety concerns.
  • ||||||||||  KB195 / Kaleido Biosci
    Trial completion date, Trial primary completion date:  UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder (clinicaltrials.gov) -  Jun 11, 2020   
    P2,  N=24, Recruiting, 
    closed the K020-218 trial due to business reasons, and not due to any safety concerns. Trial completion date: Nov 2020 --> Nov 2021 | Trial primary completion date: Oct 2020 --> Oct 2021
  • ||||||||||  KB195 / Kaleido Biosci
    Trial completion date, Trial primary completion date:  UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder (clinicaltrials.gov) -  Mar 12, 2020   
    P2,  N=24, Recruiting, 
    Trial completion date: Nov 2020 --> Nov 2021 | Trial primary completion date: Oct 2020 --> Oct 2021 Trial completion date: Jul 2020 --> Nov 2020 | Trial primary completion date: Apr 2020 --> Oct 2020